KaLy-Cell is a recognized leader in the field of in vitro ADME-Toxicology. Founded in 2004 by Prof Lysiane Richert, Ph. D., our company specializes in providing contract research services with hepatocytes to optimize the discovery, development, and approval of drugs, food additives, agrochemicals, and nutraceuticals.

Our expertise in liver cellular products from both animal and human origins allows us to evaluate inter-species differences and inter-individual variability in safety and drug efficacy. We offer a range of services, including in vitro metabolism, in vitro enzyme induction, and in vitro toxicology, as well as ex vivo toxicology. In addition to protocol-driven studies, we provide customized consultations and studies to meet our clients' specific research needs.

At KaLy-Cell, we are actively involved in innovative research in hepatocyte cell biology and in-vitro toxicology. Our cutting-edge findings are shared at conferences worldwide, and we have an extensive track record of successful projects across the EU. If you require liver cellular products or specialized research support, please contact us.

Our dedicated team is ready to assist you in optimizing your drug discovery and development process